What's Hot

My Friends Suggested a GLP-1. I Lost Weight Dancing Instead.

October 13, 2026

Johnson & Johnson raises 2026 sales outlook to 6.7%-7.1% while projecting $100.7B midpoint revenue

October 13, 2026

OpenAI Says ‘Hidden’ Recording Device Was Planted in Office

October 13, 2026

Facebook X (Twitter) Instagram

Home
News
Politics
Money
Personal Finance
Business
Economy
Investing
Markets
Technology

Facebook X (Twitter) Instagram

Home»News»Syndax wins FDA approval for leukemia drug revumenib

News

Syndax wins FDA approval for leukemia drug revumenib

By Press RoomNovember 16, 2024No Comments1 Min Read

Facebook Twitter Pinterest LinkedIn Tumblr Email

Share

Facebook Twitter LinkedIn Pinterest Email

Syndax wins FDA approval for leukemia drug revumenib

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Johnson & Johnson raises 2026 sales outlook to 6.7%-7.1% while projecting $100.7B midpoint revenue

October 13, 2026

NY Fed’s Williams sees one more rate hike this year, none in 2027

October 13, 2026

Utilities American Electric Power, Exelon upgraded at KeyBanc (AEP:NASDAQ)

October 13, 2026

Leave A Reply Cancel Reply

Save my name, email, and website in this browser for the next time I comment.

Δ

LATEST NEWS

My Friends Suggested a GLP-1. I Lost Weight Dancing Instead.

October 13, 2026

Johnson & Johnson raises 2026 sales outlook to 6.7%-7.1% while projecting $100.7B midpoint revenue

October 13, 2026

OpenAI Says ‘Hidden’ Recording Device Was Planted in Office

October 13, 2026

BTC Reverses Sharply as Bulls Fight Back

October 13, 2026

POPULAR

Business

The Business of Formula One

May 27, 2023

Business

Weddings and divorce: the scourge of investment returns

May 27, 2023

Business

How F1 found a secret fuel to accelerate media rights growth

May 27, 2023

Advertisement

Archives

Categories

Business
Crypto
Economy
Forex
Futures & Commodities
Investing
Market Data
Money
News
Personal Finance
Politics
Stocks
Technology

Your source for the serious news. This demo is crafted specifically to exhibit the use of the theme as a news site. Visit our main page for more demos.

We're social. Connect with us:

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

Agree to the our terms and policy agreement.

Facebook X (Twitter) Instagram Pinterest

Home
Buy Now

© 2026 ThemeSphere. Designed by ThemeSphere.

Type above and press Enter to search. Press Esc to cancel.